Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study
出版年份 2023 全文链接
标题
Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study
作者
关键词
-
出版物
EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 189, Issue 4, Pages 469-475
出版商
Oxford University Press (OUP)
发表日期
2023-10-12
DOI
10.1093/ejendo/lvad144
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia
- (2022) Leanne M Ward et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone
- (2022) Diana-Alexandra Ertl et al. Orphanet Journal of Rare Diseases
- Growth hormone treatment improves final height in children with X-linked hypophosphatemia
- (2022) Julia André et al. Orphanet Journal of Rare Diseases
- Impact of short stature on quality of life: A systematic literature review
- (2021) Philippe Backeljauw et al. GROWTH HORMONE & IGF RESEARCH
- Magnetic resonance imaging is a valuable tool to evaluate the therapeutic efficacy of burosumab in children with X-linked hypophosphatemia
- (2021) Volha V Zhukouskaya et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- People Are Taller in Countries With Better Environmental Conditions
- (2020) Alina German et al. Frontiers in Endocrinology
- Growth Curves for Children with X-linked Hypophosphatemia
- (2020) Meng Mao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy and safety of burosumab in children aged 1–4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial
- (2019) Michael P Whyte et al. Lancet Diabetes & Endocrinology
- FGF23 and its role in X-linked hypophosphatemia-related morbidity
- (2019) Signe Sparre Beck-Nielsen et al. Orphanet Journal of Rare Diseases
- Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
- (2019) Erik A Imel et al. LANCET
- Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations
- (2018) Douglas Chesher et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Burosumab Therapy in Children with X-Linked Hypophosphatemia
- (2018) Thomas O. Carpenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR)
- (2017) Anya Rothenbuhler et al. GROWTH HORMONE & IGF RESEARCH
- Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets
- (2017) Nadine Meyerhoff et al. PEDIATRIC NEPHROLOGY
- X-linked hypophosphatemia and growth
- (2017) R. Fuente et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Adult height, nutrition, and population health
- (2016) Jessica M. Perkins et al. NUTRITION REVIEWS
- A century of trends in adult human height
- (2016) eLife
- Should the WHO Growth Charts Be Used in France?
- (2015) Pauline Scherdel et al. PLoS One
- Therapeutic management of hypophosphatemic rickets from infancy to adulthood
- (2014) Agnès Linglart et al. Endocrine Connections
- Phenotype Presentation of Hypophosphatemic Rickets in Adults
- (2010) Signe S. Beck-Nielsen et al. CALCIFIED TISSUE INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started